Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 530 of 1,261
  1. US 10144729

    Isoxazole analogs as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  2. US 10143760

    Liver-specific constructs, factor VIII expression cassettes and methods of use thereof

    Sangamo Therapeutics, Inc. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  3. US 10143748

    B-cell reduction using CD37-specific and CD20-specific binding molecules

    Aptevo Research and Development LLC · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  4. US 10143724

    Anti-SSX-2 T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  5. US 10143721

    Combination product for the prevention of sexually transmitted infections

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  6. US 10143709

    Use of ASC and ASC-CM to treat ARDS, SARS, and MERS

    The United States of America Department of Veteran Affairs As Represented By The Technology Transfer Program · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  7. US 10143702

    Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

    RedHill Biopharma Ltd. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  8. US 10143690

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  9. US 10143660

    Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery

    The Regents of the University of California · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  10. US 10138277

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  11. US 10138255

    Piperazine derivatives as HIV protease inhibitors

    MSD R&D (China) Co. Ltd. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  12. US 10138482

    Compositions for modulating C9ORF72 expression

    Ionis Pharmaceuticals, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  13. US 10138228

    Isoxazole derivatives as FXR agonists and methods of use therof

    Enanta Pharmaceuticals, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  14. US 10138219

    Methods and compounds for restoring mutant p53 function

    PMV PHARMACEUTICALS, INC. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  15. US 10138466

    Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  16. US 10138214

    Substituted triazoles and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  17. US 10137188

    Cell lines for virus production and methods of use

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  18. US 10138220

    Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  19. US 10137193

    Methods for treating or preventing asthma by administering an IL-4R antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  20. US 10137190

    Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  21. US 10137186

    Compositions and methods for live, attenuated alphavirus formulations

    Takeda Vaccines, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  22. US 10137130

    Methods of treatment of malignancies

    Agios Pharmaceuticals, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  23. US 10137121

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  24. US 10137136

    Methods for inhibiting muscle atrophy

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.